World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00851591
Date of registration: 24/02/2009
Primary sponsor: Texas Tech University Health Sciences Center
Public title: Effect of Fenugreek on Milk Production fenugreek
Scientific title: Effect of Fenugreek on Milk Production
Date of first enrolment: September 2008
Target sample size: 56
Recruitment status: Enrolling by invitation
URL:  http://clinicaltrials.gov/show/NCT00851591
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Thomas W Hale, PhD
Address: 
Telephone:
Email:
Affiliation:  Texas Tech University Health Sciences Center
Key inclusion & exclusion criteria

Inclusion Criteria:

- Mothers 2-12 weeks postpartum

- Mothers with term infants 37 weeks gestation or older

- Mothers with poor milk supply documented by professional lactation consultants

- Mothers whose milk supply is less than 600 cc per 24 hours

- Mothers who agree not to breastfeed or provide their milk to their infants during
this study

Exclusion Criteria:

- Mothers with documented mastitis

- Mothers with breast engorgement

- Mothers with inverted nipples

- Maternal BMI greater than 35

- Mothers currently consuming Reglan, Domperidone or other drugs/herbals used to induce
milk production

- Mothers who are clinically ill or hospitalized, or taking the following medications:

1. Diuretics

2. Pseudoephedrine

3. Anticholinergics

4. Warfarin or any anticoagulant

5. An estrogen-containing birth control pill

- Mothers with Diabetes mellitus

- Mothers who have had breast surgery that could alter milk synthesis or production

- Mothers diagnosed with Polycystic ovary syndrome

- Mothers with tubular breasts or breasts with insufficient glandular tissue

- Mothers diagnosed with Asthma or atopic disease

- Mothers who are known to be allergic to peanuts or soybeans

- Mothers who are pregnant

- Mothers whose milk supply per 24 hours exceeds 600 mL

- Mothers with Obstetrical evaluation recommending exclusion



Age minimum: 18 Years
Age maximum: 45 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Lactation
Intervention(s)
Drug: fenugreek
Drug: Psyllium
Primary Outcome(s)
The main outcome variable of this study will be the quantity of milk produced. [Time Frame: day 0; day 8]
Secondary Outcome(s)
Secondary outcome variables will include milk-fat content and protein content. [Time Frame: day 0; day 8]
Secondary ID(s)
A08-3479
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history